Xilio Therapeutics, Inc. (XLO): Wutah pendapatan kuartal marang kuartal

Tandha merek Xilio (XLO)

Xilio Therapeutics, Inc. (XLO) develops selective immuno-oncology agents while maintaining balance through strategic R&D budgeting. The quarterly revenue growth rates on the GURU.Markets terminal chart capture current dynamics, where the figure remains around -47.60. Revenues are based on insurance payments for "smart" therapy, and its insulation from macroeconomic factors makes the asset defensive during recessionary periods.

xiliotx.com (XLO) - Tambahing pendapatan triwulanan saka 04.07.2022 nganti 20.11.2026

Rincian analitis perusahaan Xilio (XLO)

- rega saham lan target rega konsensus:
Analisis dhasar perusahaan:XLO - Xilio
Produk sing diprodhuksi Xilio Therapeutics Inc

For Xilio Therapeutics, Inc. (XLO), given the FDA's stringent control over drug approvals, the quarterly revenue growth rate serves as an indicator of the commercial realization of cytokine patents. This metric measures the percentage change in sales volume of the current quarter compared to the same period last year, allowing investors to assess the sustainability of business expansion and promptly identify revenue stagnation against a backdrop of high R&D costs.

Perusahaan pesaing

BeiGene Oncology - Wutah pendapatan triwulanan|HALO: Wutah pendapatan kuartal marang kuartal|Revolution Medicines Corp (RVMD) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Ascentage Pharma Group International (AAPG)|Wutah pendapatan kuartal marang kuartal CG Oncology, Inc.|Tingkat wutah pendapatan sajrone kuartal UroGen Pharma Corp URGN|Wutah pendapatan triwulanan BCAX|Personalis, Inc. - Wutah dodolan kuartal marang kuartal|Erasca - Wutah dodolan triwulanan|Tambahing pendapatan triwulanan DCTH|YMAB: Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Aura Corp|CADL: Wutah pendapatan triwulanan|ARAY - Tingkat wutah dodolan sajrone kuartal|SLS (SELLAS Life Sciences Group, Inc.) - Wutah pendapatan triwulanan|ACTU: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal citiusonc.com (CTOR)|Tingkat wutah dodolan sajrone kuartal TuHURA Biosciences|Wutah pendapatan kuartal marang kuartal Protara Therapeutics TARA|Fate Therapeutics (FATE) - Tingkat wutah pendapatan sajrone kuartal|WHWK - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal TScan Therapeutics Inc|championsoncology.com (CSBR) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan kuartal marang kuartal XBIT|Wutah dodolan triwulanan CVM|Wutah dodolan kuartal marang kuartal OSTX (OS Therapies Incorporated)|Wutah pendapatan triwulanan RADX|ARTV: Dinamika pendapatan kuartal marang kuartal|Wutah pendapatan triwulanan ANL (Adlai Nortye Ltd)|VERU - Wutah dodolan triwulanan|tempesttx.com - Wutah pendapatan triwulanan|renovarobio.com (RENB) - Wutah dodolan triwulanan|Mural Bio (MURA) - Wutah pendapatan kuartal marang kuartal|Kairos Pharma Inc (KAPA) - Wutah pendapatan triwulanan|Wutah dodolan triwulanan OKUR|CytoMed Therapeutics (GDTC) - Tingkat wutah dodolan sajrone kuartal|Wutah dodolan triwulanan CRIS (Curis Inc.)|Wutah pendapatan triwulanan Apollomics Inc. (APLM)|Wutah pendapatan kuartal marang kuartal Tharimmune Corp THAR|Advanced Biomed Corp - Wutah pendapatan kuartal marang kuartal|GNPX: Wutah dodolan triwulanan|Calidi Biotherapeutics, Inc. (CLDI) - Wutah dodolan triwulanan|SBFM: Wutah pendapatan triwulanan|Wutah dodolan triwulanan Xenetic Biosciences Inc.|Wutah pendapatan kuartal marang kuartal Salarius Pharmaceuticals Inc|PPBT: Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan AONC|BGNE (BeOne Medicines) - Tambahing pendapatan triwulanan|Checkpoint Therapeutics, Inc - Wutah dodolan triwulanan|elevationoncology.com (ELEV) - Tingkat wutah pendapatan sajrone kuartal|iCAD Inc. - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Ikena Oncology|NTBL: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Viracta (VIRX)|MOR (MorphoSys AG) - Wutah pendapatan triwulanan|NAYA: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Ascentage Pharma Group Ltd (AAPGV)